1576263 - Mirati Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - MRTX (1576263)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
43 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P6+0-0+8+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

D
2018-07-16
MRTXChen IsanEVP, Chief Medical OfficerM - OptEx$20.91+1,86734,692+6%+$39,032
DM
2018-06-26
MRTXChristensen JamieSVP, Chief Scientific OfficerM - OptEx$5.45+10,2073,394-150%+$55,618
DM
2018-06-26
MRTXChristensen JamieSVP, Chief Scientific OfficerS - Sale+OE$49.15-10,2073,394-75%-$501,630
D
2018-06-11
MRTXVenbio Select Advisor LLC10%P - Purchase$38.85+400,0004,798,101+9%+$15,540,000
2018-06-07
MRTXBoxer Capital, LLC10%P - Purchase$38.85+193,0501,565,560+14%+$7,499,993
D
2018-04-25
MRTXChen IsanEVP, Chief Medical OfficerM - OptEx$16.94+13,03831,946+69%+$220,817
D
2018-03-09
MRTXChristensen JamieSVP, Chief Scientific OfficerM - OptEx$21.39+22,0002,877-115%+$470,620
D
2018-03-09
MRTXChristensen JamieSVP, Chief Scientific OfficerS - Sale+OE$33.00-22,0002,877-88%-$726,040
D
2018-03-09
MRTXDonadio Jamie ASVP, CFOM - OptEx$17.41+12,1000-100%+$210,661
D
2018-03-09
MRTXDonadio Jamie ASVP, CFOS - Sale+OE$35.00-12,1000-100%-$423,500
D
2018-03-01
MRTXDonadio Jamie ASVP, CFOM - OptEx$6.52+51,8750-100%+$338,063
D
2018-03-01
MRTXDonadio Jamie ASVP, CFOS - Sale+OE$27.13-51,8750-100%-$1,407,145
D
2018-02-23
MRTXBaum Charles MPres, CEOM - OptEx$8.50+51,81050,932-5901%+$440,385
D
2018-02-23
MRTXBaum Charles MPres, CEOS - Sale+OE$28.03-51,81050,932-50%-$1,452,458
D
2018-02-06
MRTXChristensen JamieSVP, Chief Scientific OfficerM - OptEx$21.22+23,0002,877-114%+$488,030
D
2018-02-06
MRTXChristensen JamieSVP, Chief Scientific OfficerS - Sale+OE$30.00-23,0002,877-89%-$690,000
D
2018-01-26
MRTXChristensen JamieSVP, Chief Scientific OfficerM - OptEx$5.40+12,5002,877-130%+$67,500
D
2018-01-26
MRTXChristensen JamieSVP, Chief Scientific OfficerS - Sale+OE$26.11-12,5002,877-81%-$326,423
D
2018-01-16
MRTXChristensen JamieSVP, Chief Science OfficerM - OptEx$17.41+10,8142,877-136%+$188,272
D
2018-01-16
MRTXChristensen JamieSVP, Chief Science OfficerS - Sale+OE$27.00-10,8142,877-79%-$291,978
D
2018-01-11
MRTXChristensen JamieSVP, Chief Science OfficerM - OptEx$14.95+14,5002,877-125%+$216,805
D
2018-01-11
MRTXChristensen JamieSVP, Chief Science OfficerS - Sale+OE$22.99-14,7252,877-84%-$338,476
2017-09-21
MRTXTuesday Thirteen Inc.10%S - Sale$10.65-1,0000-100%-$10,650
D
2017-11-16
MRTXBoxer Capital, LLC10%P - Purchase$13.00+400,0003,135,966+15%+$5,200,000
2017-11-16
MRTXBroadfin Healthcare Master Fund Ltd10%S - Sale$18.05-60,0002,728,601-2%-$1,083,000
D
2017-11-16
MRTXChristensen JamieSVP, Chief Science OfficerM - OptEx$8.50+10,0002,395-131%+$85,000
D
2017-11-16
MRTXChristensen JamieSVP, Chief Science OfficerS - Sale+OE$18.00-10,2752,395-81%-$184,950
D
2017-11-16
MRTXVenbio Select Advisor LLC10%P - Purchase$13.00+650,0008,758,702+8%+$8,450,000
D
2017-11-16
MRTXVenbio Select Advisor LLC10%X - OptEx$7.8637,5008,758,7020%$294,750
D
2017-11-08
MRTXBaker Bros. Advisors LP10%X - OptEx$7.86280,26336,273-89%$2,202,867
D
2017-11-02
MRTXChristensen JamieSVP, Chief Science OfficerM - OptEx$5.50+7,4992,670-155%+$41,245
D
2017-11-02
MRTXChristensen JamieSVP, Chief Science OfficerS - Sale+OE$14.00-7,4992,670-74%-$104,986
D
2017-10-04
MRTXChristensen JamieSVP, Chief Science OfficerM - OptEx$8.50+4,0002,670-301%+$34,000
D
2017-10-04
MRTXChristensen JamieSVP, Chief Science OfficerS - Sale+OE$14.00-4,0002,670-60%-$56,000
D
2017-10-03
MRTXBoxer Capital, LLC10%X - OptEx$7.86267,966513,630-34%$2,106,213
D
2017-10-03
MRTXBoxer Capital, LLC10%X - OptEx$7.86267,966513,630-34%$2,106,213
2017-09-15
MRTXChristensen JamieSVP, Chief Science OfficerS - Sale$12.00-7702,670-22%-$9,240
2017-01-26
MRTXBraslyn Ltd.10%P - Purchase$5.45+48,1692,880,702+2%+$262,328+1+4+9
M
2017-01-23
MRTXBraslyn Ltd.10%P - Purchase$5.35+77,5332,832,533+3%+$414,573-1-7+5
M
2017-01-18
MRTXBraslyn Ltd.10%P - Purchase$5.46+61,1582,755,000+2%+$334,037+1+3+17
M
2017-01-12
MRTXBraslyn Ltd.10%P - Purchase$5.50+119,8872,693,842+5%+$658,855+1-3+11
D
2017-01-06
MRTXBraslyn Ltd.10%P - Purchase$5.60+581,8702,573,955+29%+$3,258,472-10+2
D
2017-01-06
MRTXBoxer Capital, LLC10%P - Purchase$5.60+286,163680,424+73%+$1,602,513-10+2

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top